These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15080298)

  • 1. Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease.
    Krauth MT; Simonitsch I; Aichberger KJ; Mayerhofer M; Sperr WR; Sillaber C; Schneeweiss B; Mann G; Gadner H; Valent P
    Am J Clin Pathol; 2004 Apr; 121(4):473-81. PubMed ID: 15080298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the role of angiogenesis and related factors in leukemias].
    Zhang Y; Gu J; Wang M; Ma L; Wang XL; He B; Sun M
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
    Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiogenesis in different clinical phases of chronic myeloid leukemia].
    Krasowska-Kwiecień A; Kijowski J; Łukasiewicz E; Sacha T; Foryciarz K; Majka M; Ratajczak MZ; Skotnicki AB
    Przegl Lek; 2009; 66(9):471-8. PubMed ID: 21033405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia.
    Zhelyazkova AG; Tonchev AB; Kolova P; Ivanova L; Gercheva L
    Scand J Clin Lab Invest; 2008; 68(6):492-500. PubMed ID: 18609087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].
    Zheng SE; Jin J; Tong XM; Qian WB; Xue YQ
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):920-3. PubMed ID: 17533744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia].
    Xu D; Meng FY; Zhang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):357-9. PubMed ID: 12422902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].
    Qin YZ; Ruan GR; Liu YR; Li JL; Fu JY; Wang H; Chang Y; Jiang B; Jiang Q; Jiang H; Qiu JY; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):1-5. PubMed ID: 15946498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia.
    Aumann K; Lassmann S; Schöpflin A; May AM; Wöhrle FU; Zeiser R; Waller CF; Hauschke D; Werner M; Brummer T
    Hum Pathol; 2011 May; 42(5):719-26. PubMed ID: 21292300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
    Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
    Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia.
    Verstovsek S; Kantarjian H; Manshouri T; Cortes J; Faderl S; Giles FJ; Keating M; Albitar M
    Cancer; 2003 Mar; 97(5):1248-52. PubMed ID: 12599232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia.
    Yin CC; Medeiros LJ; Glassman AB; Lin P
    Am J Clin Pathol; 2004 Jun; 121(6):836-42. PubMed ID: 15198355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.